# SkyAI, Inc.: financial statements, quarterly

SKYA · Nasdaq · CIK 1737995 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/skya.md) · [Financials](/companies/skya/financials.md) · [Filings](/companies/skya/filings.md) · [Insiders](/companies/skya/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/skya/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.1](/filings/0001493152-26-036513.md) | [0.1](/filings/0001493152-25-023381.md) | [(0.1) d](/filings/0001493152-26-014261.md) | [0.2](/filings/0001493152-26-023214.md) | [0.0 d](/filings/0001493152-26-036513.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.1](/filings/0001493152-26-036513.md) | [1.3](/filings/0001493152-25-023381.md) | [(1.9) d](/filings/0001493152-26-014261.md) | [0.2](/filings/0001493152-26-023214.md) | [0.3](/filings/0001493152-26-036513.md) |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [(0.0)](/filings/0001493152-26-036513.md) | [(1.2)](/filings/0001493152-25-023381.md) | [1.8 d](/filings/0001493152-26-014261.md) | [(0.0)](/filings/0001493152-26-023214.md) | [(0.3)](/filings/0001493152-26-036513.md) |
| Research and development | $m | [0.2](/filings/0001493152-24-045732.md) | [0.8 d](/filings/0001641172-25-000989.md) | [0.2](/filings/0001641172-25-010894.md) | [0.2](/filings/0001641172-25-023597.md) | [0.1](/filings/0001493152-25-023381.md) | [0.0 d](/filings/0001493152-26-014261.md) | [0.1](/filings/0001641172-25-010894.md) | [0.1](/filings/0001641172-25-023597.md) | [0.2](/filings/0001493152-25-023381.md) | [(0.1) d](/filings/0001493152-26-014261.md) | [0.1](/filings/0001493152-26-023214.md) | [0.3](/filings/0001493152-26-036513.md) |
| Selling, general and administrative | $m | not reported | not reported | not reported | not reported | [1.9](/filings/0001493152-25-023381.md) | [(0.2) d](/filings/0001493152-26-014261.md) | [1.4](/filings/0001493152-26-023214.md) | [1.4](/filings/0001493152-26-036513.md) | [111](/filings/0001493152-25-023381.md) | [(98.5) d](/filings/0001493152-26-014261.md) | [5.1](/filings/0001493152-26-023214.md) | [5.2](/filings/0001493152-26-036513.md) |
| Operating income | $m | [(2.4)](/filings/0001493152-24-045732.md) | [(2.9) d](/filings/0001641172-25-000989.md) | [(1.8)](/filings/0001641172-25-010894.md) | [(1.9)](/filings/0001641172-25-023597.md) | [(2.0)](/filings/0001493152-25-023381.md) | [0.2 d](/filings/0001493152-26-014261.md) | [(1.4)](/filings/0001493152-26-023214.md) | [(1.4)](/filings/0001493152-26-036513.md) | [(103)](/filings/0001493152-25-023381.md) | [(162) d](/filings/0001493152-26-014261.md) | [(86.3)](/filings/0001493152-26-023214.md) | [(23.4)](/filings/0001493152-26-036513.md) |
| Interest expense | $m | not reported | not reported | not reported | [1.0](/filings/0001641172-25-023597.md) | [0.0 d](/filings/0001493152-25-023381.md) | [0.7 d](/filings/0001493152-26-014261.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [(2.0)](/filings/0001493152-24-045732.md) | [(3.1) d](/filings/0001641172-25-000989.md) | [(1.0)](/filings/0001493152-25-023381.md) | [(2.1)](/filings/0001493152-25-023381.md) | [(1.7)](/filings/0001493152-25-023381.md) | [(4.5) d](/filings/0001493152-26-014261.md) | [1.9](/filings/0001493152-26-036513.md) | [3.6](/filings/0001493152-26-036513.md) | [(105)](/filings/0001493152-25-023381.md) | [(183) d](/filings/0001493152-26-014261.md) | [(86.2)](/filings/0001493152-26-036513.md) | [(23.3)](/filings/0001493152-26-036513.md) |
| Diluted EPS | $ per share | [(3.77)](/filings/0001493152-24-045732.md) | not reported | [(347.50)](/filings/0001641172-25-010894.md) | [(643.64)](/filings/0001641172-25-023597.md) | [(379.55)](/filings/0001493152-25-023381.md) | not reported | [38.63](/filings/0001493152-26-023214.md) | [3.58](/filings/0001493152-26-036513.md) | [(4.33)](/filings/0001493152-25-023381.md) | not reported | [(1.19)](/filings/0001493152-26-023214.md) | [(0.32)](/filings/0001493152-26-036513.md) |
| Basic EPS | $ per share | [(3.77)](/filings/0001493152-24-045732.md) | not reported | [(347.50)](/filings/0001641172-25-010894.md) | [(643.64)](/filings/0001641172-25-023597.md) | [(1.27)](/filings/0001493152-24-045732.md) | not reported | [38.63](/filings/0001493152-26-023214.md) | [3.58](/filings/0001493152-26-036513.md) | [(4.33)](/filings/0001493152-25-023381.md) | not reported | [(1.19)](/filings/0001493152-26-023214.md) | [(0.32)](/filings/0001493152-26-036513.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | period not labelled (2025-01-29) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [3.0](/filings/0001641172-25-000989.md) | [1.2](/filings/0001493152-24-019255.md) | [1.5](/filings/0001493152-24-032302.md) | [2.5](/filings/0001493152-24-045732.md) | [0.8](/filings/0001493152-26-014261.md) | not reported | [11.9](/filings/0001641172-25-010894.md) | [8.3](/filings/0001641172-25-023597.md) | [10.5](/filings/0001493152-25-023381.md) | [10.4](/filings/0001493152-26-036513.md) | [12.3](/filings/0001493152-26-023214.md) | [12.1](/filings/0001493152-26-036513.md) |
| Current assets | $m | [4.8](/filings/0001641172-25-000989.md) | [3.2](/filings/0001493152-24-019255.md) | [3.5](/filings/0001493152-24-032302.md) | [4.7](/filings/0001493152-24-045732.md) | [3.2](/filings/0001493152-26-014261.md) | not reported | [14.2](/filings/0001641172-25-010894.md) | [10.5](/filings/0001641172-25-023597.md) | [39.7](/filings/0001493152-25-023381.md) | [18.9](/filings/0001493152-26-036513.md) | [18.4](/filings/0001493152-26-023214.md) | [15.5](/filings/0001493152-26-036513.md) |
| Total assets | $m | [11.8](/filings/0001641172-25-000989.md) | [9.8](/filings/0001493152-24-019255.md) | [9.9](/filings/0001493152-24-032302.md) | [11.3](/filings/0001493152-24-045732.md) | [7.3](/filings/0001493152-26-014261.md) | not reported | [18.9](/filings/0001641172-25-010894.md) | [17.1](/filings/0001641172-25-023597.md) | [444](/filings/0001493152-25-023381.md) | [269](/filings/0001493152-26-036513.md) | [181](/filings/0001493152-26-023214.md) | [160](/filings/0001493152-26-036513.md) |
| Current liabilities | $m | [3.7](/filings/0001641172-25-000989.md) | [2.8](/filings/0001493152-24-019255.md) | [2.6](/filings/0001493152-24-032302.md) | [4.6](/filings/0001493152-24-045732.md) | [5.2](/filings/0001493152-26-014261.md) | not reported | [8.6](/filings/0001641172-25-010894.md) | [2.4](/filings/0001641172-25-023597.md) | [10.6](/filings/0001493152-25-023381.md) | [4.7](/filings/0001493152-26-036513.md) | [2.2](/filings/0001493152-26-023214.md) | [2.9](/filings/0001493152-26-036513.md) |
| Total liabilities | $m | [3.9](/filings/0001641172-25-000989.md) | [2.9](/filings/0001493152-24-019255.md) | [2.7](/filings/0001493152-24-032302.md) | [4.7](/filings/0001493152-24-045732.md) | [5.3](/filings/0001493152-26-014261.md) | not reported | [8.8](/filings/0001641172-25-010894.md) | [2.5](/filings/0001641172-25-023597.md) | [10.7](/filings/0001493152-25-023381.md) | [4.7](/filings/0001493152-26-036513.md) | [2.2](/filings/0001493152-26-023214.md) | [3.1](/filings/0001493152-26-036513.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [7.6](/filings/0001493152-25-023381.md) | [3.1](/filings/0001493152-26-036513.md) | not reported | not reported |
| Shareholders' equity | $m | [7.9](/filings/0001493152-26-014261.md) | [6.9](/filings/0001493152-25-023381.md) | [7.2](/filings/0001493152-25-023381.md) | [6.5](/filings/0001493152-25-023381.md) | [2.0](/filings/0001493152-26-036513.md) | [5.9](/filings/0001493152-25-023381.md) | [10.1](/filings/0001493152-26-036513.md) | [14.5](/filings/0001493152-26-036513.md) | [433](/filings/0001493152-25-023381.md) | [264](/filings/0001493152-26-036513.md) | [179](/filings/0001493152-26-036513.md) | [157](/filings/0001493152-26-036513.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(2,014) d](/filings/0001493152-24-045732.md) | [(2,362) d](/filings/0001641172-25-000989.md) | [(1,889)](/filings/0001641172-25-010894.md) | [(1,639) d](/filings/0001641172-25-023597.md) | [(1,643) d](/filings/0001493152-25-023381.md) | [771 d](/filings/0001493152-26-014261.md) | [(1,418)](/filings/0001493152-26-023214.md) | [(859) d](/filings/0001493152-26-036513.md) | [(9,467) d](/filings/0001493152-25-023381.md) | [753 d](/filings/0001493152-26-014261.md) | [(2,677)](/filings/0001493152-26-023214.md) | [(2,995) d](/filings/0001493152-26-036513.md) |
| Capital expenditure | $k | not reported | not reported | [2.9](/filings/0001641172-25-010894.md) | [16.5 d](/filings/0001641172-25-023597.md) | [50.3 d](/filings/0001493152-25-023381.md) | [69.1 d](/filings/0001641172-25-000989.md) | [90.4](/filings/0001641172-25-010894.md) | [1,869 d](/filings/0001641172-25-023597.md) | [1,442 d](/filings/0001493152-25-023381.md) | not reported | not reported | not reported |
| Share repurchases | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [1,589](/filings/0001493152-26-023214.md) | [423 d](/filings/0001493152-26-036513.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [9.2](/filings/0001493152-23-041085.md) | [10.7](/filings/0001493152-24-019255.md) | [11.7](/filings/0001493152-24-032302.md) | [0.5](/filings/0001493152-24-045732.md) | [0.0](/filings/0001641172-25-010894.md) | [0.0](/filings/0001641172-25-023597.md) | [0.0](/filings/0001493152-25-023381.md) | [0.0](/filings/0001493152-26-023214.md) | [1.0](/filings/0001493152-26-036513.md) | [24.3](/filings/0001493152-25-023381.md) | [72.6](/filings/0001493152-26-023214.md) | [72.1](/filings/0001493152-26-036513.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 42,982,506 at 2026-08-04, from the cover of the [10-Q filed 2026-08-07](/filings/0001493152-26-036513.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.